Biolinq is a medical technology company focused on the development of the Biolinq Shine™ glucose sensor, which is the first fully autonomous, needle-free glucose sensor integrating glucose, activity, and sleep information in a single device. The sensor aims to provide a simple user experience and a new level of engagement in glucose monitoring.

Biolinq Shine™ features a color-changing LED light system to reveal glucose excursions in real time without the need for a phone. The sensor tracks physical activity and sleep to provide context to glucose levels, presenting actionable insights to support healthier decisions. The device is FDA cleared and intended for use by individuals age 22 years or older not on insulin to help manage glycemic control in a non-invasive way.

The system includes an app for personalized insights and trend tracking to support lifestyle and behavior modifications related to glucose management.